By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced a definitive agreement to buy certain assets from Indian firm Labindia for an undisclosed amount.

Labindia has been a distributor of Life Tech's Applied Biosystems products, including the SOLiD sequencing system and Ambion RNA reagents, since 1994. The deal creates a full service business, allowing Life Tech to supply ABI and Invitrogen products directly to customers, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.